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Clinical guideline · Evidence-based medicine · Consensus · Prostate cancer: Treatment, Diagnosis, Rehabilitation Summary Evidence-based guidelines are important sources of knowledge in everyday clinical practice. In 2005, the German Society for Urology decided to develop a highquality evidence-based guideline for the early detection, diagnosis and treatment of the different clinical manifestations of prostate cancer. The guideline project started in 2005 and involved 75 experts from 10 different medical societies or medical organizations including a patient organization. The guideline was issued in September 2009 and consists of 8 chapters, 170 recommendations, and 42 statements. Due to the broad spectrum of clinical questions covered by the guideline and the high number of participating organizations and authors, the organizers faced several methodological and organizational challenges. This article describes the methods used in the development of the guideline and highlights critical points and challenges in the development process. Strategies to overcome these problems are suggested which might be beneficial in the development of new evidencebased guidelines in the future. 
Organization, Responsibilities and Time Lines
The steering committee consisted of 5 urologists nominated by the DGU, 4 radiooncologists nominated by the German SocietyforRadio-Oncology(DEGRO)and1medicaloncol-ogistrepresentingtheGermanSocietyforHaematologyand Oncology(DGHO).Inordertoensureexpertiseinspecialissuesofprostatecancermanagementandtopursueaninterdisciplinary approach, the steering committee invited other scientific societies involved in the management of prostate cancer and patient organizations to participate in the guideline development process. The Association of the Scientific Medical Societies in Germany (AWMF) and the Deutsche Krebsgesellschaft(DKG,GermanCancerSociety)supervised thedevelopment.In2006,theÄrztlichesZentrumfürQuali-tätinderMedizin(ÄZQ,AgencyforQualityinHealthCare) was commissioned for methodical and scientific input and project management. The organizational structure of the guidelineprojectisshowninfigure1.
In order to guarantee a structured development process, thedifferentaspectsofprostatecancertreatmentweresummarizedunder5mainthemes:preventionandearlydetection, diagnosisandstaging,treatmentoflocalizedprostatecancer, treatment of advanced prostate cancer, rehabilitation, supportivecare,psychooncology,andqualityoflife.
The5themesweresubdividedinto42keyquestionsdeal-ingwithclinicalissuesofhighprioritytotheguidelinegroup. Priorities were set within the steering committee and discussedbothwithmethodologyexpertsfromtheÄZQandthe AWMFandalsowithguidelineauthorsduringtheconsensus conferences.Workinggroupswereformedforeachkeyquestionconsistingof2-8clinicalexpertsand/orpatientrepresentatives. Authors for working groups were selected by their scientificmedicalsociety.Thecompositionofworkinggroups wasdefinedbythesteeringcommitteeanddependedonthe specific key question. While there was a higher quota of urologistsinworkinggroupsonsurgicaltopicssuchasprostatectomy, lymphadenectomy or biopsy, working groups on radiotherapy were formed by a higher percentage of radiooncologists.Ingeneral,themajorityofexpertsintheguideline working groups were urologists (66%), followed by radiooncologists (17%), representatives of other specialties andpatientrepresentatives.Themainreasonsforthisdistribution were the leading role of the DGU in the guideline development process and the fact that, in Germany, most patientswithprostatecancerarediagnosedbyurologists.
Röllig/Nothacker/Wöckel/Weinbrenner/Wirth/ Kopp/Ollenschläger/Weißbach advising responsibility and did not take part in the voting process.Thedevelopmentprocessofguidelinerecommendationsisdepictedinfigure2.
Public Consultation and Final Editing
Following the last consensus conference, all guideline chapterswerepublishedonlineforpubliccommentsfor4weeks. Publiccommentswerediscussedandnecessarychangeswere made by the steering committee. The final version of the guidelinewaspresentedattheannualmeetingoftheGerman SocietyofUrology(DGU)inSeptember2009 [10] .
Results

Atotalof75clinicalexpertsandpatientrepresentativesfrom
10 organizations and groups and 4 EBM specialists were involved in the development of the guideline. 6 conferences were held, each taking 1-2 days. As a result of 56 separate literaturesearches,12,189hitswerescreenedand420publica-tionswereincludedasasourceofevidence.Basedon42key
Thefirstmeetingoftheguidelinegrouptookplacein2005, followed by 5 consensus conferences between September 2007andJune2009.
Identification of Evidence and Formulation of Recommendations
A systematic literature search was performed for each key question. Both evidence-based guidelines and primary evidence were used for the development of recommendations. The search for international reference guidelines was performed using the database of the Guidelines International Network (G-I-N [4, 5] ,(iii)NationalInstitutefor HealthandClinicalExcellence(NICE,2008) [6] ,and(iv)the DutchGuidelinePlatform(EBRO,2007) [7] .TheCochrane Library and PubMed were searched for systematic reviews; PubMed was used as a resource for primary literature. In general,onlyrecentevidenceofthelast5yearswasselected. Allsearchresultsweremadeaccessiblefortheparticipating expertsviaaninternettool.Theresultsoftheselectedpublicationswereextractedanddisplayedinevidencetables.The levelofevidenceofeachpublicationwasclassifiedusingthe classification of the Scottish Intercollegiate Guidelines Network(SIGN) [8] .Basedontheevidencetables,thebodyof evidence was summarized and suggestions for guideline recommendations were made by members of the working groupsandevidence-basedmedicine(EBM)expertsfromthe ÄZQ. Upon completion, the draft chapters were sent electronicallytotheclinicalexpertsanddiscussedbetweenclinical and EBM experts in telephone meetings. Depending on the complexity of the topic, one or two telephone meetings werenecessaryforeachchapter.
Reaching Consensus and Grading Recommendations
All recommendations had to pass a two-step consensus processconsistingof(i)aNominalGroupProcess(NGP) [9] ingroupsof20-25clinicalexpertsundersupervisionandguid-anceofEBMspecialistsand(ii)generalvotingofallguideline authors.Allexpertsmetinconsensusconferences,discussing thechaptersviaNGPandvotingforfinalrecommendations. Additionally to the wording of the recommendations, the strengthofrecommendationwasdeterminedintheconsensus process. Only recommendations with an acceptance rate of >75%wereincludedintheguideline.EBMexpertshadonly An electronic newsletter was used to update and motivate authorsandcreateasenseofownershipandofcommitment totheproject.
Intheprocessofguidelinedevelopment,itbecameobvious that evidence was lacking for a considerable number of key questions,so-calledevidence gaps.Whereevidencewaslacking, high-quality source guidelines were used as a starting point for a structured expert consensus. Apart from gaps in availableevidence,therewasalsoasignificantnumberoftopics not covered by the initial project plan. Some topics regarded as essential by the steering committee were then addedtotheoriginalplanwhileothersweredeferredforthe future guideline update. In order to account for the quick turnover of medical knowledge, the steering committee decidedtosubjecttheguidelinetoashort-termupdateprocess followingtheconceptofasocalled'living guideline'.Thiswill includeastructuredliteraturesearchofselectedtopicsaswell astheadditionofupto12newaspectsnotcoveredbythecur-rent guideline. Within an annual formal consensus process, recommendationsmaybechangedandnewrecommendations questions,8chapterswereformed,containing170recommen-dationsand42statements.Thechapterheadingsareshownin table1.Themajorityofrecommendations(64%)weregraded as strong recommendations (grade A, n = 109). 1/5 of the recommendations(21%)wereassignedaweakrecommendation(gradeB,n=36)and15%oftherecommendationswere labeled as open or optional (grade 0, n = 25). 23 comments werereceivedduringthepublicconsultationperiod,leading to5adjustmentsofrecommendations.
Challenges, Problems and Solutions
Due to the large number of people involved in the project, sufficient and constructive communication between experts andpatientslocatedindifferentregionsofGermany,Austria andSwitzerlandformedthebiggestchallengefortheproject management. Different approaches to certain clinical problemsbetweenvaryingnumbersofexpertsofvariousspecialtiesaggravatedpossiblecommunicationproblems.Forexample,thevalueandsignificanceofmagneticresonanceimaging (MRI) and transrectal ultrasound in primary diagnosis and stagingoflocalizedprostatecancerwasahighlycontroversial topic.2approachesweresuccessfullyusedinordertofacili-tate communication. Firstly, the process of conducting the literature search and selection was made transparent using an internet site with a professional literature database ('refshare').Theparticipatingexpertswereabletoreproduce theliteraturesearchonline,accesstheselectedabstractsand full texts and add important publications not yielded by the searchstrategy.Ofevengreaterimportancewastheprovision of draft chapters including suggestions for recommendations 
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maybeapprovedifnecessary.Theprocesswillbebasedon existingorganizationalstructuressuchasthesteeringcommittee and authors from the guideline group. Members of preexistingauthorgroupswillcoverthe12newtopics.Theinternet tool will be used for additions and provision of new literature.
Conclusions and Implications for Future Guideline Projects
Thedevelopmentofacomprehensiveevidence-basedguideline (S3 level) takes up a considerable amount of time and financial resources and requires efficient project management. In the initial planning phase of a new S3 guideline project,itisessential -to prioritize topics of interest and to be selective in the choiceoftopics, -tobalancethedesiretoinvolveasmanyexpertsaspossiblewiththelogisticsofcoordinatinglargegroups-wefeel that the development process becomes very complex if more than 35 experts are involved and if there are large inequalitiesinnumbersofexpertsofdifferentspecialties,
